Athyrium Capital Management is a leading investment management platform dedicated to global opportunities in the healthcare sector.
View Portfolio
2008
Founding Year
$5B+
Capital Invested
85+
Portfolio Companies
20+
Professionals
Why Choose Athyrium
Our funds have flexible investment mandates that can accommodate the objectives of portfolio companies.
Relationships with Industry–Leading Companies
Recent Investments and Press Releases
January 5, 2026
Global Expansion with Strategic Investment and Alliance with a Leading U.S. MedSpa Platform OrangeTwist as Part of Broader Growth Strategy
December 1, 2025
Omeros Corporation Announces Closing of Asset Purchase and License Agreement with Novo Nordisk for Omeros’ Clinical-Stage MASP-3 Inhibitor Zaltenibart (OMS906)
November 24, 2025
RVL Pharmaceuticals Announces Leadership Appointments to Accelerate Next Phase of Growth and Commercial Momentum